Sheba Medical Center has deployed a new accelerated, AI-powered cancer diagnostics research platform to improve patient diagnosis, treatment, and outcomes. It utilizes solutions of various Israeli startups, including that of Imagene (see here previously). https://www.israelnationalnews.com/news/375264

The AI digital biopsy from Israel’s Imagene (see here previously) not only identifies if someone has cancer but also what mutation is responsible for the anomaly. This is something pathologists cannot determine using a microscope. With results in minutes, not … Continue reading →

The death of his mother led Dean Bitan to found Israel’s Imagene (see here previously). The startup has developed tech that can conduct a full molecular analysis on a digitized biopsy image in real time and give a result in … Continue reading →

Israel’s Imagene AI develops fast AI-based cancer diagnostics to help identify personalized treatment. Using a digitized biopsy image, Imagene delivers real-time precision-based molecular analysis, increased accuracy and reducing the time required for results, from several weeks to just two minutes. … Continue reading →

The PlayBeyondBio initiative has selected nine Israeli startups for its program for companies developing solutions for future challenges to healthcare systems. C2i Genomics, Nucleai, Itamar medical, Medial Earlysign, iBex, Octopus.health, Imagene, iCardio.ai and Cordio Medical. https://www.calcalistech.com/ctech/articles/0,7340,L-3912456,00.html